Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis
Conclusions
The current meta-analyses provide evidence that several medications for AUDs are effective and safe and encourage the expanded use of these medications in the clinical setting. Our review found that acamprosate (2–3 g/d), disulfiram (250–500 mg/d), baclofen (30 mg/d), and oral naltrexone (50 mg/d) had the best evidence for improving abstinence and heavy drinking for patients with AUD.
PROSPERO
CRD42020208946.
Source: Journal of Addiction Medicine - Category: Addiction Tags: Review Source Type: research
More News: Abilify | Addiction | Alcoholism | Baclofen | Carbamazepine | Clinical Trials | Gabapentin | Lyrica | Neurontin | Topamax